SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-22-133527
Filing Date
2022-04-29
Accepted
2022-04-29 16:02:14
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFC14A d352677ddefc14a.htm DEFC14A 330224
2 GRAPHIC g352677page001.jpg GRAPHIC 264795
3 GRAPHIC g352677page002.jpg GRAPHIC 186378
  Complete submission text file 0001193125-22-133527.txt   953488
Mailing Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE, BLDG. A, SUITE 4900 SAN FRANCISCO CA 94129 (415) 659-8940
MITHRIL II LP (Filed by) CIK: 0001669609 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A

Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-40703 | Film No.: 22875068
SIC: 2836 Biological Products, (No Diagnostic Substances)